Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ocular Therapeut (NQ: OCUL ) 9.840 +0.610 (+6.61%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Ocular Therapeut < Previous 1 2 3 4 5 6 7 Next > Ocular Therapeutix™ to Present Pre-Clinical and Clinical Data at the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting April 25, 2022 From Ocular Therapeutix, Inc. Via Business Wire The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More April 17, 2022 Biotech stocks retreated in the week ending April 14, lock-stepping with the broader market. The news flow was light during the holiday-shortened week and ahead of the imminent first-quarter reporting... Via Benzinga Ocular Therapeutix™ to Present Clinical Data at the 2022 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting April 14, 2022 From Ocular Therapeutix, Inc. Via Business Wire Earnings Scheduled For February 28, 2022 February 28, 2022 Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (... Via Benzinga Expert Ratings For Ocular Therapeutix November 09, 2021 Ocular Therapeutix (NASDAQ:OCUL) has observed the following analyst rating... Via Benzinga Stocks That Hit 52-Week Lows On Thursday April 21, 2022 On Thursday, 236 companies hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Wednesday April 20, 2022 On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new... Via Benzinga Recap: Ocular Therapeutix Q4 Earnings February 28, 2022 Ocular Therapeutix (NASDAQ:OCUL) reported its Q4 earnings results on Monday, February 28, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings... Via Benzinga Ocular Therapeutix™ To Report Fourth Quarter and Year-End 2021 Financial Results February 22, 2022 From Ocular Therapeutix, Inc. Via Business Wire Ocular Therapeutix™ Announces Upcoming Presentation of Interim OTX-TKI Phase 1 Clinical Trial Data at Angiogenesis, Exudation, and Degeneration 2022 Meeting and OTX-TIC Phase 1 Clinical Trial at Glaucoma 360 February 11, 2022 From Ocular Therapeutix, Inc. Via Business Wire Stocks That Hit 52-Week Lows On Friday February 18, 2022 On Friday, 313 companies hit new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week... Via Benzinga AffaMed Therapeutics, licensee of DEXTENZA® in Certain Asian Markets, Doses Their First Patient in Clinical Trial Evaluating the Safety and Efficacy of DEXTENZA® in China in Cataract Surgery Patients January 18, 2022 From Ocular Therapeutix, Inc. Via Business Wire Ocular Therapeutix™ to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference January 04, 2022 From Ocular Therapeutix, Inc. Via Business Wire Ocular Therapeutix's Dexamethasone Ophthalmic Insert Meets Primary Goal In Dry Eye Disease Trial December 06, 2021 Ocular Therapeutix Inc (NASDAQ: OCUL) announced topline results from its Phase 2 trial of OTX-DED (dexamethasone intracanalicular ophthalmic insert) for the short-... Via Benzinga Ocular Therapeutix™ Announces Topline Results for Phase 2 Clinical Trial of OTX-DED for the Short-Term Treatment of Dry Eye Disease December 06, 2021 From Ocular Therapeutix, Inc. Via Business Wire Ocular Therapeutix™ to Participate at Two Upcoming Investor Conferences November 15, 2021 From Ocular Therapeutix, Inc. Via Business Wire Ocular Therapeutix Stock Gains As Court Invalidates Drug Delivery Patent From Mati November 09, 2021 Ocular Therapeutix Inc (NASDAQ:OCUL) announce... Via Benzinga Topics Intellectual Property Exposures Intellectual Property 12 Health Care Stocks Moving In Tuesday's Intraday Session November 09, 2021 Gainers Frequency Therapeutics (NASDAQ:FREQ) stock rose 10.94% to $7.51 during Tuesday's regular session. The current volume of 277.7K shares is 160.43% of Frequency... Via Benzinga Ocular Therapeutix™ Announces Success in Patent Appeal Brought by Mati Therapeutics, Inc. November 09, 2021 From Ocular Therapeutix, Inc. Via Business Wire Ocular Therapeutix: Q3 Earnings Insights November 08, 2021 Ocular Therapeutix (NASDAQ:OCUL) reported its Q3 earnings results on Monday, November 8, 2021 at 04:01 PM. Here's what investors need to know about the announcement. Earnings... Via Benzinga Ocular Therapeutix™ Reports Third Quarter 2021 Financial Results and Business Update November 08, 2021 From Ocular Therapeutix, Inc. Via Business Wire Ocular Therapeutix™ Announces Update from the Centers for Medicare and Medicaid Services (CMS) for the Reimbursement of DEXTENZA® November 05, 2021 From Ocular Therapeutix, Inc. Via Business Wire Earnings Scheduled For November 8, 2021 November 08, 2021 Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •... Via Benzinga Ocular Therapeutix™ to Present Data at the American Academy of Optometry Annual Meeting 2021 November 01, 2021 From Ocular Therapeutix, Inc. Via Business Wire Ocular Therapeutix™ To Report Third Quarter 2021 Financial Results October 29, 2021 From Ocular Therapeutix, Inc. Via Business Wire Ocular Therapeutix™ to Present Data at the American Academy of Ophthalmology (AAO) 2021 Virtual Annual Meeting October 28, 2021 From Ocular Therapeutix Via Business Wire What 5 Analyst Ratings Have To Say About Ocular Therapeutix October 25, 2021 Ocular Therapeutix (NASDAQ:OCUL) has observed the following analyst ratings... Via Benzinga How The Future Looks For Last Week's Biggest Losers: Vinco Ventures, Atea Pharmaceuticals And More October 25, 2021 Last week, the five biggest stock market losers declined between about 75% and 37%. Below is a look at each stock and what they may have in the cards going forward. Galera... Via Benzinga 10 Biggest Price Target Changes For Monday October 25, 2021 Wells Fargo boosted Bank of America Corporation (NYSE:B... Via Benzinga 55 Biggest Movers From Friday October 25, 2021 Gainers Phunware, Inc. (NASDAQ: PHUN) shares jumped 471.2% to close at $8.74 on Friday. Phunware shares jumped over 45% on Thursday, possibly in sympathy with Digital World... Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.